TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
NKTX

Nkarta Inc

Healthcare · Biotechnology

2.90$ +3.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow NKTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
-79.1% -15,918.0% -11,300,259.7% – – – – –
2.8% 347.5% 204,155.8% – – – – –
2.8% 820.7% 1,752,727.3% – – – – –
2.8% 111.8% 12,440,779.2% – – – – –
-80.5% 1,888.5% -215,064.9% – – – – –
11.6% 1,670.9% 1,950,909.1% – – – – –
-11.6% -15,855.6% -54,566,493.5% – – – – –
1.3% 37,782.6% 68,956,623.4% – – – – –
91.4% 5,187.8% – – – – – –
1.3% 42,970.1% 85,666,753.2% – – – – –
-89.4% 11,196.4% 19,800,000.0% – – – – –
-90.7% -17,588.9% -13,251,168.8% – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?